(PRWEB) April 02, 2015
The blood screening market size is expected to reach $2.55 billion by 2019 from $1.5 billion in 2014 at a CAGR of 10.4%. This market is categorized on the basis of products and services, technologies, end users and regions.
The major factors contributing to the growth of the blood screening market include the increasing number of blood donations and blood donors, increasing awareness regarding the safety of donated blood, increasing patient affordability, and increasing demand of donated blood. Furthermore increasing adoption of NAT by governments of various countries is another major factor providing impetus for growth of this market. For instance, in 2014 the Japanese Red Cross entered into an agreement with Grifols (Spain) for nucleic acid testing (NAT) for the total blood donated in Japan. This agreement is expected to aid the growth of the blood screening market during the forecast period.
Speak to Analyst @ http://www.marketsandmarkets.com/speaktoanalyst.asp?id=267747042
Apart from comprehensive regional and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on the key players in the blood screening market and product portfolios, developments and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, regional focus, change in strategic approach, R&D investments for innovations in products and technologies and levels of output in order to remain successful.
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology